Osel

Osel's mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBP) that prevent or treat disorders caused by disruptions in the human microbiome. In 2003, Osel was one of the first companies to receive FDA authorization to test live bacterial therapies and has been a pioneer in the LBP field.Osel, Inc. is at the forefront of developing a new class of drugs known as Live Biotherapeutic Products.